Analogic in the 2019 Global Diagnostic Imaging Sector
This strategic assessment of Analogic, one of the worlds leading diagnostic imaging companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report presents a comprehensive analysis of the companys performance, capabilities, goals, and strategies in the global diagnostic imaging market.
SECTION I: EXECUTIVE SUMMARY
- A 3-15 page synopsis of key sections.
- History of the company’s diagnostic imaging business evolution, which is important to
understanding the corporate culture, management mentality and strategies.
- Recent acquisitions, divestitures and major organizational changes.
- Current organizational structure.
SECTION III: SENIOR MANAGEMENT
- Names, titles and background of key executives.
SECTION IV: FACILITIES AND EMPLOYEES
- Administrative, manufacturing and R&D facilities in the U.S. and abroad.
- Manufacturing practices.
- New plants under construction.
- The U.S. and international work force size and distribution.
- Internally developed and acquired diagnostic imaging and related technologies, including
X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.
SECTION VI: PRODUCT PORTFOLIO
- Placements and installed base of major systems in the U.S. and abroad, by modality.
- Review of major product lines.
- Applications, advantages and weaknesses of leading products.
SECTION VII: MARKETING TACTICS
- Promotional tactics.
- Distribution approaches.
- Product service and support.
- Customer relations.
SECTION VIII: FINANCIAL ANALYSIS
- Estimated sales and operating profit by division, geographic region and product line.
- Five-year sales and operating profit performance.
SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
- Estimated R&D budget.
- Research facilities and staff.
- New technologies, systems and applications in development.
SECTION X: COLLABORATIVE ARRANGEMENTS
- Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
- Terms of collaborative agreements and specific products involved.
SECTION XI: STRATEGIC DIRECTION
- Specific business, new product development and marketing strategies.
- Anticipated acquisitions, joint ventures and divestitures.
SECTION I: EXECUTIVE SUMMARY
- A 3-15 page synopsis of key sections.
SECTION II: BUSINESS ORGANIZATION
- History of the companys diagnostic imaging business evolution, which is important to understanding
the corporate culture, management mentality and strategies.
- Recent acquisitions, divestitures and major organizational changes.
- Current organizational structure.
SECTION III: SENIOR MANAGEMENT
- Names, titles and background of key executives.
SECTION IV: FACILITIES AND EMPLOYEES
- Administrative, manufacturing and R&D facilities in the U.S. and abroad.
- Manufacturing practices.
- New plants under construction.
- The U.S. and international work force size and distribution.
SECTION V: TECHNOLOGICAL KNOW-HOW
- Internally developed and acquired diagnostic imaging and related technologies, including X-ray,
ultrasound, MRI, CT, nuclear medicine, PET, PACS, and others.
SECTION VI: PRODUCT PORTFOLIO
- Placements and installed base of major systems in the U.S. and abroad, by modality.
- Review of major product lines.
- Applications, advantages and weaknesses of leading products.
SECTION VII: MARKETING TACTICS
- Promotional tactics.
- Distribution approaches.
- Product service and support.
- Customer relations.
SECTION VIII: FINANCIAL ANALYSIS
- Estimated sales and operating profit by division, geographic region and product line.
- Five-year sales and operating profit performance.
SECTION IX: R&D EXPENDITURES AND MAJOR PROGRAMS
- Estimated R&D budget.
- Research facilities and staff.
- New technologies, systems and applications in development.
SECTION X: COLLABORATIVE ARRANGEMENTS
- Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
- Terms of collaborative agreements and specific products involved.
SECTION XI: STRATEGIC DIRECTION
- Specific business, new product development and marketing strategies.
- Anticipated acquisitions, joint ventures and divestitures.
Analogic Full Year Operating Financial
Analogic 2023 Full Year Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of the Competitive
USD 750 View ReportAnalogic 2023 Third Quarter Operating and Financial Review
Analogic 2023 Third Quarter Operating and Financial Review--SWOT Analysis, Technological Know-How, M&A, Senior Management, Goals and Strategies in the Global Diagnostic Imaging Industry This report is part of the Competitive
USD 750 View ReportDevelopment Trends and Opportunities in the Global Smartphone Radio Frequency Industry (pre-order)
The global mobile communication radio frequency (RF) market has undergone significant changes with the advent of 5G communication. Qualcomms introduction of a comprehensive solution from baseband to antenna has gradually
USD 1500 View ReportBlood Banking Market Shares in the US Europe Japan
2023 Blood Banking Market Shares in the US, Europe, and Japan--Competitive Analysis of Leading and Emerging Market Players This new report provides blood banking market shares for the following
USD 1850 View ReportFill The Form For Sample Request